Nevertheless, partial restoration of pSTAT1 signaling in response to IFN-α indicates a degree of plasticity in this pathway, which makes it a candidate for potential therapeutic interventions targeting aging-related and chronic infection-related immune dysfunction. This evidence concerns the gene IFNA1 and immune system disorder.